NOS3 and cardiac hypertrophy: Nitric oxide and its downstream target, protein kinase G, are generally considered to blunt hypertrophy [30], [31] whereas nitric oxide synthase-3 uncoupling induces marked cardiac hypertrophy, dilation, and dysfunction [32].